Capra Biosciences Inc.
Sterling, VA
- UEI
- UMYRLBCXW9T5
- CAGE
- 8NG19
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 101 International Dr Suite 100, Sterling, VA 20166, USA
- Website
- caprabiosciences.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Bioindustrial Manufacturing And Design Ecosystem | FA86502125028 | $50,000 | |
| Bioindustrial Manufacturing And Design Ecosystem | FA86502125028 | $519,390 |
Similar vendors
About the company
Capra Biosciences Inc., a for-profit biosciences manufacturer headquartered in Sterling, Virginia, holds a multiple-award Other Transaction IDV from DARPA with a $13.1 million ceiling for Phase 1 biotech research and operates as a subrecipient on Army materiel-focused federal grants. The company's federal footprint spans a single prime vehicle and two sub-award relationships across two distinct customer agencies, with $5.2 million obligated against the combined potential value of $13.1 million across all awards.
The vendor's prime position derives from a January 2024 DARPA Other Transaction IDV focused on transcriptomics and optogenetics for lipid expression (TOGLE) under the Biological Technologies Office SWITCH program — a $13.1 million vehicle supporting applied research in advanced biotech manufacturing. This represents Capra's sole prime award. The company's sub-award activity concentrates with the Bioindustrial Manufacturing and Design Ecosystem as the prime grantee, with two federal grant sub-awards: an April 2025 ADP26 award and an April 2026 sub-award for in-fermenter cell data streams using wireless networks of free-floating microbial-electronic sensors.
Customer concentration is split between DARPA (1 award, $13.1 million combined potential value) and the Department of the Army Materiel Command TACOM Life Cycle Management Command (2 awards, dollar value not disclosed in the source). The Army-linked work via TACOM represents 67% of recent awards by count, but DARPA anchors the disclosed dollar value. Capra's work falls under National Defense R&D Services and applied research classification, positioning the vendor as a specialized biotech supplier for defense-focused fermentation, cellular sensing, and transcriptomics applications. The vendor has received three awards over three years (one per year in 2024, 2025, and 2026), with no recompete or expiration cliff noted in the source data.
Quick answers
Is Capra Biosciences Inc. registered in SAM.gov?
Yes. Capra Biosciences Inc.'s SAM.gov registration is active through January 18, 2027.
On GovTribe
See Capra Biosciences Inc.'s full federal record
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors